American Oncology Network (AONC) Financials

Balance sheets

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 2022

Total Assets

$394.8 M(-8.3%)$430.8 M(+2.1%)$421.9 M(+12.7%)$374.5 M(-5.0%)$394.0 M--$326.2 M-

Current Assets

$271.2 M(-11.4%)$306.3 M(-5.5%)$324.0 M(+16.6%)$277.8 M(-6.9%)$298.4 M--$242.0 M-

Non Current Assets

$123.6 M(-0.7%)$124.5 M(+27.1%)$98.0 M(+1.4%)$96.7 M(+1.1%)$95.6 M--$84.2 M-

Total Liabilities

$340.7 M(-9.6%)$376.9 M(+3.0%)$365.8 M(+20.4%)$303.7 M(+0.9%)$300.9 M--$264.2 M-

Current Liabilities

$199.9 M(-13.7%)$231.6 M(-1.0%)$233.8 M(+38.3%)$169.0 M(+0.7%)$167.9 M--$140.9 M-

Long Term Liabilities

$140.9 M(-3.1%)$145.4 M(+10.1%)$132.0 M(-2.0%)$134.7 M(+1.3%)$133.0 M--$123.3 M-

Shareholders Equity

-$38.8 M(-255.3%)$25.0 M(+124.4%)-$102.5 M(-5.9%)-$96.7 M(+65.0%)-$276.3 M--$62.0 M-

Book Value

-$103.8 M(-159.7%)-$40.0 M(+76.1%)-$167.4 M(-3.5%)-$161.7 M(+52.6%)-$341.3 M--$62.0 M-

Working Capital

$71.4 M(-4.5%)$74.7 M(-17.1%)$90.1 M(-17.1%)$108.8 M(-16.6%)$130.5 M--$101.1 M-

Cash And Cash Equivalents

$19.4 M(-42.5%)$33.8 M(-54.9%)$74.9 M(+162.6%)$28.5 M(-44.8%)$51.7 M--$26.9 M-

Accounts Payable

$155.5 M(-17.9%)$189.5 M(+0.6%)$188.3 M(+47.5%)$127.6 M(+6.0%)$120.4 M--$106.5 M-

Accounts Receivable

$128.0 M(+2.1%)$125.4 M(-5.2%)$132.3 M(+2.4%)$129.2 M(-8.4%)$141.0 M--$136.1 M-

Short Term Debt

$12.4 M(-1.0%)$12.5 M(+58.0%)$7.9 M(+0.5%)$7.9 M(+1.6%)$7.8 M--$9.6 M-

Long Term Debt

$131.3 M(-2.3%)$134.4 M(+11.4%)$120.6 M(+0.2%)$120.4 M(-1.8%)$122.7 M--$117.5 M-

Total Debt

$143.7 M(-2.2%)$146.9 M(+14.3%)$128.6 M(+0.2%)$128.3 M(-1.6%)$130.4 M(+100.0%)$0.0(0%)$0.0(-100.0%)$127.1 M(+100.0%)$0.0

Debt To Equity

-2.4(-163.9%)3.7(+565.8%)-0.8(+4.8%)-0.8(-186.2%)-0.3--1.3-

Current Ratio

1.4(+3.0%)1.3(-5.0%)1.4(-15.2%)1.6(-7.9%)1.8--1.7-

Quick Ratio

1.1(+1.8%)1.1(-9.2%)1.2(-13.0%)1.4(-11.0%)1.6--1.5-

Inventory

$49.3 M(-9.2%)$54.3 M(+22.6%)$44.3 M(-0.6%)$44.6 M(+17.8%)$37.8 M--$36.5 M-

Retained Earnings

-$103.5 M(-55.1%)-$66.7 M(+62.0%)-$175.6 M(-8.5%)-$161.8 M(+52.6%)-$341.4 M--$25.8 M-

PB Ratio

-0.5(-42.9%)-0.3(-2.9%)-0.3(+5.6%)-0.4(-38.5%)-0.3----

Income statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 2022

EPS

-$0.2(-72.7%)-$0.1(+91.0%)-$1.2(-62.7%)-$0.8(-22.9%)-$0.6(-100.0%)$0.0(0%)$0.0(-100.0%)$0.3(+100.0%)$0.0

TTM EPS

-$2.3(+15.6%)-$2.7(-4.3%)-$2.6(-89.7%)-$1.4(-301.9%)-$0.3(-224.6%)$0.3(0%)$0.3(0%)$0.3(+100.0%)$0.0

Revenue

$470.3 M(+8.4%)$434.0 M(+19.1%)$364.3 M(+12.4%)$324.2 M(-3.6%)$336.3 M(+6.8%)$315.0 M(+3.7%)$303.7 M(+1.1%)$300.4 M(+1.0%)$297.3 M

TTM Revenue

$1.6 B(+9.2%)$1.5 B(+8.9%)$1.3 B(+4.7%)$1.3 B(+1.9%)$1.3 B(+3.2%)$1.2 B(+34.9%)$901.5 M(+50.8%)$597.7 M(+101.0%)$297.3 M

Total Expenses

$468.5 M(+6.2%)$441.3 M(+15.2%)$383.2 M(+11.6%)$343.4 M(+2.2%)$336.1 M(+6.6%)$315.3 M(+4.3%)$302.3 M(+2.8%)$294.0 M(+1.0%)$291.1 M

Operating Expenses

$34.7 M(-5.4%)$36.7 M(+29.9%)$28.3 M(+1.4%)$27.9 M(+10.7%)$25.2 M(+5.4%)$23.9 M(+0.8%)$23.7 M(+15.9%)$20.5 M(-12.7%)$23.4 M

Cost Of Goods Sold

$433.7 M(+7.2%)$404.6 M(+14.0%)$354.9 M(+12.5%)$315.6 M(+1.5%)$310.9 M(+6.7%)$291.4 M(+4.6%)$278.5 M(+1.8%)$273.6 M(+2.2%)$267.6 M

TTM Cost Of Goods Sold

$1.5 B(+8.9%)$1.4 B(+8.9%)$1.3 B(+6.4%)$1.2 B(+3.6%)$1.2 B(+3.9%)$1.1 B(+35.5%)$819.7 M(+51.5%)$541.2 M(+102.2%)$267.6 M

Gross Profit

$36.5 M(+24.3%)$29.4 M(+213.0%)$9.4 M(+8.9%)$8.6 M(-66.1%)$25.4 M(+7.8%)$23.6 M(-6.5%)$25.2 M(-6.1%)$26.8 M(-9.6%)$29.7 M

TTM Gross Profit

$83.9 M(+15.3%)$72.8 M(+8.7%)$67.0 M(-19.1%)$82.8 M(-18.0%)$101.0 M(-4.0%)$105.3 M(+28.8%)$81.7 M(+44.6%)$56.5 M(+90.4%)$29.7 M

Gross Margin

7.8%(+14.8%)6.8%(+162.4%)2.6%(-3.0%)2.7%(-64.8%)7.6%(+1.1%)7.5%(-9.9%)8.3%(-7.0%)8.9%(-10.5%)10.0%

Operating Profit

$1.8 M(+124.4%)-$7.3 M(+61.1%)-$18.9 M(+2.0%)-$19.3 M(-9186.3%)$212.0 K(+161.1%)-$347.0 K(-123.5%)$1.5 M(-76.8%)$6.4 M(+2.2%)$6.2 M

TTM Operating Profit

-$43.7 M(+3.5%)-$45.3 M(-18.3%)-$38.3 M(-113.7%)-$17.9 M(-331.8%)$7.7 M(-43.8%)$13.8 M(-2.5%)$14.1 M(+11.7%)$12.6 M(+102.2%)$6.2 M

Operating Margin

0.4%(+122.5%)-1.7%(+67.4%)-5.2%(+12.8%)-5.9%(-10000.0%)0.1%(+154.6%)-0.1%(-122.5%)0.5%(-77.0%)2.1%(+1.4%)2.1%

Net Income

-$1.1 M(-129.5%)$3.6 M(+146.2%)-$7.8 M(-109.1%)-$3.8 M(-109.3%)-$1.8 M(-100.0%)$0.0(0%)$0.0(-100.0%)$2.6 M(+100.0%)$0.0

TTM Net Income

-$9.0 M(+7.4%)-$9.8 M(+27.1%)-$13.4 M(-141.5%)-$5.5 M(-795.4%)$797.0 K(-69.2%)$2.6 M(0%)$2.6 M(0%)$2.6 M(+100.0%)$0.0

Net Margin

-0.2%(-127.7%)0.8%(+138.6%)-2.1%(-85.3%)-1.2%(-118.9%)-0.5%(-100.0%)0.0%(0%)0.0%(-100.0%)0.9%(+100.0%)0.0%

EBIT

$314.0 K(+121.8%)-$1.4 M(+92.9%)-$20.4 M(+0.0%)-$20.4 M(+25.5%)-$27.3 M(-223.9%)-$8.4 M(-26465.6%)$32.0 K(-98.8%)$2.7 M(-58.0%)$6.5 M

TTM EBIT

-$41.8 M(+39.8%)-$69.5 M(+9.2%)-$76.5 M(-36.3%)-$56.1 M(-70.0%)-$33.0 M(-3887.3%)$871.0 K(-90.6%)$9.3 M(+0.3%)$9.3 M(+42.0%)$6.5 M

EBITDA

$4.9 M(+52.7%)$3.2 M(+120.5%)-$15.8 M(+2.3%)-$16.2 M(+30.8%)-$23.4 M(-450.0%)-$4.3 M(-195.3%)$4.5 M(-33.8%)$6.7 M(+3.3%)$6.5 M

TTM EBITDA

-$23.8 M(+54.3%)-$52.1 M(+12.6%)-$59.6 M(-51.5%)-$39.4 M(-139.6%)-$16.4 M(-221.8%)$13.5 M(-24.0%)$17.7 M(+33.6%)$13.3 M(+103.3%)$6.5 M

Selling, General & Administrative Expenses

$34.7 M(-5.4%)$36.7 M(+29.9%)$28.3 M(+1.4%)$27.9 M(+10.7%)$25.2 M(+5.4%)$23.9 M(+0.8%)$23.7 M(+15.9%)$20.5 M(-12.7%)$23.4 M

TTM SG&A

$127.6 M(+8.1%)$118.1 M(+12.2%)$105.3 M(+4.5%)$100.7 M(+8.0%)$93.3 M(+1.9%)$91.5 M(+35.4%)$67.6 M(+54.0%)$43.9 M(+87.3%)$23.4 M

Depreciation And Amortization

$4.6 M(-1.0%)$4.7 M(+2.8%)$4.5 M(+8.8%)$4.2 M(+5.9%)$3.9 M(-5.8%)$4.2 M(-5.5%)$4.4 M-$13.1 M

TTM D&A

$18.0 M(+3.9%)$17.3 M(+2.9%)$16.9 M(+0.7%)$16.7 M(+33.3%)$12.6 M(-42.1%)$21.7 M(+23.9%)$17.5 M-$13.1 M

Interest Expense

$1.9 M(+2.2%)$1.8 M(+4.0%)$1.8 M(-8.0%)$1.9 M(+25.1%)$1.5 M(-1.2%)$1.6 M(+9.5%)$1.4 M(+2.5%)$1.4 M(+49.7%)$924.0 K

TTM Interest Expense

$7.4 M(+4.8%)$7.0 M(+4.2%)$6.8 M(+5.4%)$6.4 M(+9.1%)$5.9 M(+11.5%)$5.3 M(+41.6%)$3.7 M(+61.4%)$2.3 M(+149.7%)$924.0 K

Income Tax

$0.0(+100.0%)-$324.0 K(-111.2%)$2.9 M(+4094.2%)$69.0 K(-78.1%)$315.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Income Tax

$2.6 M(-10.7%)$3.0 M(-9.9%)$3.3 M(+753.6%)$384.0 K(+21.9%)$315.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

PE Ratio

-----38.0(-0.3%)38.1(+3.1%)37.0-

PS Ratio

0.0(+200.0%)0.0(-75.0%)0.0(0%)0.0(-42.9%)0.1----

Cashflow statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 2022

Cash From Operations

-$28.1 M(+17.2%)-$33.9 M(-175.2%)$45.1 M(+477.5%)-$12.0 M(-207.5%)-$3.9 M(-100.3%)-$1.9 M(-490.3%)-$329.0 K-$1.6 M

TTM CFO

-$28.8 M(-521.7%)-$4.6 M(-117.0%)$27.3 M(+250.9%)-$18.1 M(-194.1%)-$6.2 M(-861.0%)-$641.0 K(-149.3%)$1.3 M-$1.6 M

Cash From Investing

$15.0 M(+975.7%)-$1.7 M(-212.6%)$1.5 M(+114.0%)-$10.9 M(+40.9%)-$18.4 M(-400.9%)-$3.7 M(-38.7%)-$2.6 M--$13.1 M

TTM CFI

$3.9 M(+113.4%)-$29.4 M(+6.2%)-$31.4 M(+11.7%)-$35.5 M(-44.0%)-$24.7 M(-27.4%)-$19.4 M(-23.4%)-$15.7 M--$13.1 M

Cash From Financing

-$1.3 M(+76.2%)-$5.5 M(-2059.8%)-$254.0 K(+13.9%)-$295.0 K(-124.6%)$1.2 M(-97.8%)$54.5 M(+51973.3%)-$105.0 K-$15.8 M

TTM CFF

-$7.3 M(-51.8%)-$4.8 M(-108.8%)$55.1 M(-0.3%)$55.3 M(-0.5%)$55.6 M(-20.8%)$70.1 M(+348.0%)$15.7 M-$15.8 M

Free Cash Flow

-$34.5 M(+9.1%)-$38.0 M(-192.6%)$41.0 M(+378.7%)-$14.7 M(-125.8%)-$6.5 M(-7.5%)-$6.1 M(-95.2%)-$3.1 M--$3.4 M

TTM FCF

-$46.2 M(-153.9%)-$18.2 M(-232.7%)$13.7 M(+145.1%)-$30.4 M(-93.8%)-$15.7 M(-24.6%)-$12.6 M(-92.9%)-$6.5 M--$3.4 M

CAPEX

$6.5 M(+59.5%)$4.0 M(-2.1%)$4.1 M(+49.9%)$2.8 M(+4.9%)$2.6 M(-36.2%)$4.1 M(+48.4%)$2.8 M-$5.1 M

TTM CAPEX

$17.4 M(+28.2%)$13.6 M(-0.6%)$13.6 M(+11.0%)$12.3 M(+28.9%)$9.5 M(-20.3%)$11.9 M(+52.7%)$7.8 M-$5.1 M

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------